Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2026-04-15 @ 6:32 PM
Study NCT ID:
NCT01068795
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2010-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
Sponsor:
HaEmek Medical Center, Israel
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0048-09-EMC ANTIXA-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None